Introduction
Ramadan fasting is one of the cardinal articles of Islam commonly known as “the five
Pillars of Islam”.[[1]],[[2]] Fasting is obligatory for all healthy adult and adolescent Muslims.[[1]],[[2]] Fasting is ordained from the time of completing the puberty which varies from 12
to 16 years of age. Fasting starts from early dawn (Sohur) to sunset (Iftar). During
this period, a fasting person has to abstain from eating and drinking. Islam has allowed
many categories of people to be exempted from fasting, for example, prepubertal children,
travelers, the sick, the elderly, pregnant, and lactating women and individuals with
chronic illnesses such as type 1 diabetes mellitus (T1DM).
Sick individuals and children are exempted from fasting Ramadan. However, many patients
insist on following the fast, often without the approval of their physicians.[[3]],[[4]] Ramadan fasting represents a significant shift in meal timing and content for practicing
Muslims. This naturally affects the bodily homeostasis, metabolic environment, fluid
balance, and interaction of foods, drugs, and disease.
Fasting by T1DM patients might predispose to acute complications due to the loss of
fine balance between insulin action and carbohydrate supply in different directions
in the two different times of the fasting cycle.[[5]]. The global literature production on health aspects of Ramadan fasting is notably
relatively low in general as shown in recent review of the whole of publications in
one year (2017)[[6]]. Similarly, a more focused recent bibliometric analysis quantified the global production
on Ramadan and diabetes over the last three decades also showed a low volume of scholarly
work.[[7]] There are several review articles and clinical practice guidelines in general with
a predictable emphasis on adults.[[8]],[[9]],[[10]],[[11]],[[12]] However, there are no comprehensive guidelines specifically addressing fasting
safety or its impact on diabetes control in children and adolescents. Hence, we aimed
to undertake this comprehensive review to narrate the available evidence and expert
opinion thematically. This exercise may be particularly useful to inform discussion
groups aiming to develop guidelines about this particular high-risk group.
Emerging Concepts
The key areas covered include safety of Ramadan fasting, risk stratification, management
strategy, nutritional advice, insulin therapy adjustment with a particular focus on
T1DM patients on multi-dose insulin injections or insulin pump therapy and conventional
monitoring methods. The findings are presented thematically.
Should type 1 diabetes mellitus fast in Ramadan?
There is a striking difference of opinion between experts regarding the appropriateness,
feasibility, and safety of fasting by adolescents with diabetes. Many experts are
of the view that patients with T1DM who fast during Ramadan are at a very high risk
to develop adverse events, and accordingly, they should be advised to make use of
the religious allowance or “Fatwah's” that they should not fast at all based on the
Islamic Fiqh Academy [[2]],[[10]],[[11]] or The Mufti of Egypt.[[12]] This group warns that the risks of diabetic ketoacidosis (DKA), severe hypoglycemia,
hyperglycemia, dehydration, and thrombotic episodes are increased. Lack of proper
prefast assessment, management, and diabetes education have been stumbling blocks
in facilitating Ramadan fasting in T1DM patients in general.[[13]]
On the other hand, some experienced physicians believe that fasting during Ramadan
is safe for T1DM patients, including adolescents and older children, with good glycemic
control who can do regular self-monitoring and are under close professional supervision.[[14]] The strategies to ensure the safety of T1DM adolescents who are planning to fast
include the following: Ramadan-focused medical education, pre-Ramadan medical assessment,
following a healthy diet and physical activity pattern, modification in insulin regimen,
and blood glucose (BG) monitoring as advised by the physician. Some experts uphold
the opinion that recent studies have demonstrated that individuals with T1DM who are
otherwise healthy and stable, provided enough evidence that they can fast during Ramadan
if they comply with the Ramadan focused management plan and are under close professional
supervision. Mohsin et al. elaborated how to assess, counsel, monitor, and manage
people with T1DM who wish to fast during Ramadan.[[15]]
Physiology of fasting in children and adolescents
Several studies focused on the changes in glucose homeostasis during Ramadan fasting.[[16]],[[17]],[[18]],[[19]],[[20]],[[21]],[[22]] The salient findings are summarized in [[Table 1]]. It is noteworthy that some of these studies were mixed or conducted in adults;
however, they remain valuable for the present discussion. The collective aims of these
studies were to establish the BG patterns, variability and timing, and risk of hypoglycemia
and hyperglycemia [[Table 1]]. However, the studied groups of patients were far from homogeneous in age, metabolic
status, and therapeutic regimens. A typical plasma glucose curve during Ramadan has
been illustrated using flash glucose monitoring (FGM) and continuous glucose monitoring
(CGM) methodology. BG rises predictably and invariably after the first evening meal
to variable durations, mounts a smaller postprandial rise after the predawn meal and
demonstrates a progressive declining leading to the end of the fasting period [[Figure 1]].[[20]] However, it is the order of magnitude of these changes in relationship to meals
and medications that has been the focus of the management maneuvers.
Table 1: Studies providing insights into glucose and metabolic homeostasis during and around
Ramadan fasting during different modalities of monitoring
Figure 1: The contrasting metabolic environments reflected in plasma glucose levels before
Ramadan (a), during Ramadan fasting (b) and after Ramadan fasting (c) illustrated
by ambulatory glucose profile on the left and a representative single day curve of
interstitial glucose levels using Flash Glucose Monitoring technology of Free Style
Libre (Abbotts). Redrawn from Beshyah et al. (ref 20)
The ability and safety of fasting during Ramadan in adolescents with T1DM was investigated
by Kaplan and Afandi using CGM in 21 adolescents (mean age 15 ± 4 years) who had diabetes
for 6 ± 3 years.[[18]] Patients adjusted the pump basal rate according to the eating pattern during Ramadan.
The averages of all daily readings were calculated to express the BG values every
5 min and the values during fasting and eating hours were compared. Eighteen were
on the insulin pump, and three were on MDI regimen using insulin analogs. Patients
were able to fast on 85% of the potential days, and 76% could fast 25 days or more.
No severe hypoglycemia, DKA, or emergency room visits were reported. The average BG
during fasting was predictably lower than that during the eating hours. Hypoglycemia
and hyperglycemia were observed in 16.7% and 29.3% of the 24-h CGM readings, respectively.
Hypoglycemia occurred more during fasting hours than the eating hours (14.2% vs. 2.5%,
P < 0.05), whereas hyperglycemia was observed more often in the eating than in fasting
hours (17% vs. 12%, P < 0.05). A wide BG fluctuation during fasting and eating hours
and some episodes of unreported hypoglycemia were noted in the CGM data. The authors
asserted that frequent BG monitoring is essential to recognize the incidence of hypoglycemia
and take the proper action to control it. Furthermore, El-Hawary et al. compared three
insulin regimens (regular insulin/NPH, regular insulin/insulin glargine, and premixed
insulin) in 53 children.[[19]] They were recruited 3 months before Ramadan and were provided with intensive education;
28 completed the fasting. A significant drop in postRamadan fructosamine (P < 0.001)
was observed. BG at three-time points, pre-Iftar, pre-Sohur, and mid-day were higher
in the first insulin regimen compared to the other two (P = 0.004). Similarly, Musleh
et al. prospectively observed 21 T1DM adolescents (median age 14 years).[[22]] The fasting days, the reasons for not fasting were noted, and BG and insulin doses
were recorded in specially prepared dairies. Patients were able to fast 80% of the
total possible days. The reasons for not fasting were hypoglycemia (29%), hyperglycemia
(19%), or other reasons (52%). There was a minimal increment in the mean glycated
hemoglobin (HbA1c) after Ramadan (from 8.3% to 8.5%) but none of the participants
developed severe hypoglycemia or DKA. Although this was a small study, those on insulin
pump managed to fast more days (82.8% vs. 77.3%). Afandi et al. related the CGM data
during fasting in 21 adolescents (15 ± 4 years), with T1DM for 6 ± 3 years, to their
preRamadan diabetes control. They used CGM during fasting for a minimum of 3 days.
Hypoglycemia, hyperglycemia, and severe hyperglycemia were captured. Patients were
categorized as well-controlled, or poorly controlled according to the prefasting HbA1c
(≤8% or >8%, respectively). The percentages of hypoglycemia, hyperglycemia, and severe
hyperglycemia were significantly higher in the poorly controlled group, whereas a
higher percentage of normoglycemia was evident in the well-controlled group. The overall
duration of hypoglycemia, hyperglycemia, and severe hyperglycemia in the poorly controlled
group were longer than in the controlled group. In another study, glycemic excursions
during Ramadan fasting were evaluated by Lessan et al. who investigated the short-term
safety of this practice in different groups of patients with diabetes.[[16]] CGM was performed before, during, and after Ramadan fasting in 56 patients with
diabetes and 7 healthy volunteers. There was a significant difference in mean CGM
curves during Ramadan in patients with diabetes showing a slow fall during fasting
hours followed by a rapid rise in glucose level after iftar. The magnitude of this
excursion was the greatest in the insulin-treated group. Pallayova et al. also using
CGM studied the physiological effects of Ramadan fasting in young nondiabetic adults.[[21]] CGM was captured before, in the middle, and after Ramadan to assess glucose exposure
and variability. A large number of data points were obtained from 18 nonobese nondiabetic
young adults. The CGM profiles showed an increase in the hyperglycemic area under
the curve (AUC)[[17]] after Ramadan compared to both before (P = 0.004) and during Ramadan (P = 0.003),
along with an increased glucose variability after Ramadan (P = 0.014).
Attitude, complications, and ability to fast
The attitude toward fasting, frequency of complications, and impact on glycemic control
were investigated in 65 children with T1DM.[[23]] Questionnaires were filled, HbA1c levels were recorded, and log books indicating
symptomatic hypoglycemia and hyperglycemia leading to breaking fast were obtained.
Majority of patients were willing to fast, and 75% were encouraged by parents to do
so; 57% and 26% fasted more than half and all of the month, respectively. Just over
half (52%) had at least one episode of hypoglycemia, 29% had hyperglycemia, and one
episode of ketoacidosis occurred. All patients broke fast in response to symptomatic
hypoglycemia/hyperglycemia. The authors reported no significant difference in the
frequency of complications between the pump or the multiple daily injection (MDI)
groups. The mean HbA1c increased from 8.6% to 8.8%, but the difference was not statistically
significant.
Diabetes self-management education for Ramadan
Eid et al. evaluated the feasibility of promoting safe Ramadan fasting through diabetes
self-management education (DSME) and determined the effect of such education on hypoglycemic
episodes.[[24]] The DSME sessions started 2–3 weeks before Ramadan and included one experimental
fasting day during the 1st week and one during the 2nd week. Participants' HbA1c,
serum fructosamine levels, and self-monitoring of BG (SMBG) logs were collected. Two-thirds
of the 21 participants who were intending to fast completed the program. Their mean
HbA1c was 6.7 ± 1.6%, and SMBG results showed no significant difference in mean BG
levels before and after Ramadan. Serum fructosamine after Ramadan decreased by 10%.
The mean number of hypoglycemic events before Ramadan decreased in Ramadan. Differences
between Group 1 (those without hypoglycemia, n = 8) and Group 2 (those with hypoglycemia,
n = 6) were not significant for all three variables.
Dietary habits and nutrients intake
The effects of fasting on the dietary habits and nutrients intake were examined in
54 adolescents (13–18 years old) with T1DM who were permitted by their physicians
to fast and had no medical complications.[[25]] They were evaluated before, during, and after Ramadan. The participants fasted
a mean of 21.7 days, had 0.45 kg weight loss, and their energy and macronutrients
intake increased significantly during Ramadan. The authors concluded that changes
in lifestyle, physical activity, and dietary pattern are characteristics of the month
of Ramadan and these affect both diabetic and nondiabetic participants. They emphasized
that adherence of adolescents with T1DM to dietary and nutritional guidelines are
vital but may sometimes be difficult to attain and maintain.
Safety of fasting during Ramadan in adolescents with diabetes
In addition to the above studies, Zabeen et al.[[26]] evaluated the safety of fasting in 33 children and adolescents with T1DM in a prospective
observational study. Patients with their caregivers received intensive education and
instructions were provided by diabetic educators, dieticians, and physicians on insulin
adjustment, home BG monitoring and dietary adjustments before Ramadan. The majority
(60.6%) of the youngsters were able to complete their fasting during Ramadan. Two
groups were examined, i.e. those who completed fasting versus patients who broke the
fast. BG, HbA1c, body weight, and insulin dose before and after Ramadan in the two
groups showed no significant difference. Hence, the authors concluded that children
older than 11 years of age with T1DM on conventional twice-a-day regimen could fast
safely during Ramadan provided they receive proper prefasting education and intensive
follow-up.
Diabetic ketoacidosis
A critical appraisal of the literature noted that the increased risk of DKA has been
suggested in the older writings and reiterated ever since.[[27]] The authors suggested that from physiological principles, DKA is not readily precipitated
by the “stress-free” metabolic environment associated with Ramadan fasting with the
exception of cases involved in classical risk factors for metabolic decompensation.
Furthermore, recent studies could not document any increase in observed DKA during
Ramadan fasting in retrospective, prospective, and database reviews. However, no age-based
subgroup analysis was included include an in the review [[27]] nor in the recent series.[[28]] Future analyses should consider the data on an age basis. Isolated case reports
include a 15-year-old Muslim boy with T1DM who presented with DKA during the day-time
fasting of Ramadan month when DKA occurred due to omitting prelunch insulin combined
with dehydration and overeating during the permitted sunset-to-sunrise time.[[29]] Furthermore, a case euglycemic DKA was reported in newly diagnosed T1DM of 14 years
old boy due to starvation during Ramadan fasting.[[30]] The importance of evaluation of acid-base state, urine glucose, and ketone values
at in all newly diagnosed T1DM during Ramadan cannot be overemphasized.
Hypoglycemia
Risk of hypoglycemia during Ramadan is a core concern and is discussed in different
contexts throughout this review. The frequency, timing, and severity of hypoglycemia
were elucidated by Afandi et al.[[31]] elucidated further in 25 adolescents with T1DM (mean age was 16 ± 3 years) using
the FGM system. Differences in percentage and the total duration of hypoglycemia were
compared between different times of the day and night related to the eating pattern
in Ramadan. The mean glucose level was 11.1 ± 4.7 mmol/L, and the overall time spent
in hypoglycemia was 5.7% ± 3.0%. The average daily time spent in hypoglycemia was
1.39 h per patient. Over two-thirds of hypoglycemia occurred between 11:00–19:00 and
similar proportion of hypoglycemia were between 61 and 70 mg/dl. Similar to adults,
hypoglycemia remains the most feared complication from fasting in insulin-treated
patients. All educational programs must stress the need to stop fasting without delay
when hypoglycemia occurs.
Insulin therapy during fasting
Multiple daily injections
A large volume of work has now accumulated on the use of insulin during Ramadan fasting.[[32]],[[33]],[[34]],[[35]],[[36]] The published data on insulin therapy using MDI are summarized in [[Table 2]]. Al-Khawari et al.[[33]] examined the ability and safety of fasting in young people with T1DM on multiple
injections versus twice-daily premixed insulin regimen.[[33]] All patients showed a tendency to high BG at the time of commencing their fast.
Those on twice daily insulin continued to have hyperglycemia during the day while
those on basal-bolus insulin showed a steady fall in BG toward normal by sunset time.
Although there was a greater tendency to hypoglycemia in the basal-bolus group, this
was successfully prevented by reducing the dose of basal insulin by 10%–20%. The authors
recommend that it is safe for adolescents with diabetes to fast during Ramadan provided
they (a) cut their basal insulin by the proposed amount and (b) continue to monitor
their BG regularly. Furthermore, Kadiri et al. compared insulin lispro with regular
human insulin concerning BG control and frequency of hypoglycemia in patients with
T1DM who wished to fast during the month of Ramadan.[[34]] Insulin lispro or regular human insulin was given together with NPH insulin, twice
daily before the morning and evening meals, for 2 weeks each in an open-label, randomized,
cross-over design, and 64 patients completed the protocol. SMBG was undertaken in
the morning and evening, and 1 h and 2 h after the post-Iftar on three consecutive
days at the end of each treatment period. The 2-h BG excursion after the postsunset
meal was significantly lower with insulin lispro than with regular human insulin.
Daily insulin doses did not differ between treatments but compliance with a recommended
time of injection was better with insulin lispro. Hypoglycemia incidence (23% of patients
on insulin lispro vs. 32% of patients on regular human insulin, P = 0.004). Frequency
(expressed as episodes/patient/30 days) was less on insulin lispro than regular human
insulin (0.8 vs. 2.3; P < 0.001). Both postprandial glycemic excursions and hypoglycemic
episodes were better on the insulin analog.
Table 2: Summary of the studies observing or investigating multiple daily injection insulin
regimens for patients with diabetes who fast during Ramadan
Insulin pump therapy
Several reports on the use of continuous subcutaneous insulin infusion (CSII or insulin
pump therapy) during Ramadan fasting were published over the past decade.[[37]],[[38]],[[39]],[[40]],[[41]],[[42]] The published data on insulin pump therapy are summarized in [[Table 3]].
Table 3: Summary of studies involving insulin pump therapy during Ramadan
The first report on using insulin pump in children and adolescents with T1DM during
Ramadan fasting was by Bin-Abbas from Saudi Arabia in 2008.[[37]] Five adolescents on pump therapy showed interest in fasting, their results of BG
levels and the rate of hypoglycemic episodes were compared with four adolescents on
conventional insulin therapy. Although a small study, the authors claimed significantly
lower levels of HbA1c and lower risks of hypoglycemia. Furthermore, early work by
Hawli et al.[[38]] evaluated the need for changes in basal insulin regimen in five patients with T1DM
fasting during Ramadan. Patients used regular human insulin were appropriately instructed
to break the fast after any episode of hypoglycemia, severe hyperglycemia, or any
hyperglycemia associated with ketonuria. BG concentrations did not change significantly
with fasting. SMBG decreased at 4 p.m. and increased in the evening and morning (10
p.m. and 8 a.m., respectively). Furthermore, the basal insulin requirement decreased
in four patients during the fast. No cases of DKA or severe hypoglycemia were reported.
Benbarka et al.[[39]] reported their experience with insulin pumps during Ramadan in 63 adolescents and
young adults with T1DM who were using insulin pump for 20 ± 10 months. Forty-nine
(22 ± 7 years) fasted, and 14 elected not to fast. Patients who fasted have diabetes
for 9.6 ± 5.6 years, and 39 of them fasted the whole month with no problems, Nearly
half of the patients decreased their basal insulin by 5%–50% of their pre-fasting
doses; 17 patients had nonsevere hypoglycemia requiring breaking the fast. Unusual
hyperglycemia was reported in 9 patients (18.4%).[[39]] Twelve patients had fructosamine levels measured both before and immediately after
Ramadan and showed postfasting improvement (4.0 ± 0.6–3.6 ± 0.6 mmol/L. P =0.007).
The same group reported a similar study with the additional use of CGM augmentation.[[40]] They confirmed that the advantages provided by insulin pump use in patients with
diabetes were enhanced by the use of CGM in 21 patients. All fasted for a median of
29 days and adjusted their insulin as per their usual practices. The total insulin
administered during Ramadan was not different from that in the pre-Ramadan period,
and no major hypoglycemic episodes occurred. More recently, the use of low-glucose
suspend (LGS) feature of insulin pumps was to shown reduce exposure to hypoglycemia
significantly without compromising safety in 60 patients (aged 15.6 ± 2.7 years).[[41]] One group used the sensor with LGS feature, and other turned off LGS feature. The
AUC <70, AUC <60 mg/dL (P = 0.0001) and >240 mg/dL (P = 0.006) were all reduced with
the LGS feature. None in the LGS group broke the fast compared to 15 in the second
group (P = 0.001). No episodes of severe hyperglycemia or DKA were noticed in either
group.
Should basal insulin dose be decreased to reduce the risk of hypoglycemia?
Deeb et al.[[42]] addressed the specific question of whether lowering the basal insulin dose during
Ramadan reduces the frequency of symptomatic hypoglycemia as was proposed by previous
workers.[[39]],[[40]] Seventy-five children and adolescents with T1DM aged 14.5 years intended to fast
during Ramadan. The days fasted, hypoglycemia, and basal insulin doses were recorded.
Logbooks were examined, and glucometers and insulin pumps were downloaded. Sixty-eight
patients' results were analyzed (41 on pump and 27 on MDI). Mean HbA1c was 7.9 ± 1.2%
and 8.4 ± 1.3% for the pump and the MDI, respectively (P = 0.007). Thirty-nine patients
had hypoglycemia leading to breaking fast. The mean number of episodes of breaking
fast was 3 (1–8). Thirty-five of the 68 patients had reduced basal insulin. However,
there was no significant difference in the frequency of hypoglycemia between those
who decreased and those who did not decrease the basal insulin dose (P < 0.10). Fifteen
patients on MDI and 24 patients on pumps had at least one episode of breaking fast.
Six and 18 of the patients on MDI and pumps, respectively, reduced basal insulin (P
> 0.10).
Multiple daily injections versus insulin pump
The benefits and risks of CSII or MDI in patients with diabetes who fast during Ramadan
were examined by two groups recently using systematic review and meta-analysis.[[43]],[[44]] Loh et al.[[43]] pooled data from 17 observational studies involving 1699 patients treated with
either CSII or nonCSII regimens. Whereas, Gad et al.[[44]] assessment included a total of 9 studies. Loh et al.[[43]] concluded that the CSII regimen had lower rates of severe hypoglycemia and hyperglycemia/ketosis,
but a higher rate of nonsevere hyperglycemia than premixed/MDI regimens. They suggested
that appropriate patient selection with regular supervised fine-tuning of basal insulin
rate with intensive glucose monitoring may mitigate the residual hypoglycemia risk
during Ramadan. However, Gad et al.[[44]] were more conservative and concluded that studies assessing the effect of CSII
or MDI in patients with T1DM who fast during Ramadan are limited to observational
studies and show no difference in the change in HbA1c, weight, or lipids during Ramadan.
The differences in conclusions calls for more carefully conducted prospective studies
for head-to-head comparisons.
What is the possible role of newer insulin?
Two groups attempted to answer this question.[[42]],[[43]] Although the experience described here was in adult patients, it could be translated
to children and adolescents as the agents are used by young patients. Kalra [[36]] documented the utility and safety of insulin degludec (IDeg) and insulin degludec
aspart (IDegAsp) in persons with type 2 diabetes mellitus (T2DM), observing Ramadan
fast. A single-center observational study conducted on six persons who either switched
to IDeg or IDegAsp a month before Ramadan or changed the time of administration of
IDegAsp at the onset of Ramadan. Participants were kept under regular monitoring and
counseled before, during, and after Ramadan. Four persons, who changed from premixed
insulin to IDegAsp, experienced a 12%–18% dose reduction after 14 days. At the onset
of Ramadan, the Sohur dose was reduced by 30%, and this remained unchanged during
the fasting month. The Iftar dose had to be increased by 4 units. One person who shifted
from NPH to IDeg demonstrated a 25% dose reduction at 20 days, without any further
change in insulin requirement during Ramadan. One person who changed the time of injection
of IDegAsp from morning to night reported no dose change. No major hypoglycemia was
reported. Furthermore, Hassanein et al.[[45]] compared the efficacy and safety of (IDegAsp and biphasic insulin aspart 30 (BIAsp
30) before, during, and after Ramadan fasting in patients with T2DM in a multinational,
randomized, treat-to-target trial, patients with T2DM who intended to fast and were
on basal, pre- or self-mixed insulin ± oral antidiabetic drugs for ≥90 days were randomized
(1:1) to IDegAsp twice daily (BID) or BIAsp 30 BID. These data suggest that IDeg and
IDegAsp are effective, safe, and well-tolerated means of achieving glycemic control
in individuals with T2DM who wish to fast. Further studies in young patients with
T1DM are needed.
Monitoring of blood glucose during fasting
Capillary blood glucose
Capillary BG remains the most widely used method of monitoring. Pragmatically, measurements
during Ramadan is based on the same principles of SMBG outside Ramadan with the times
being related to meals and medications with allowance for the difference in the glucose
profiles during and outside Ramadan [[Figure 1]]. To assess the adequacy of postprandial control, readings are recommended 2 h after
Iftar, and for the predawn meal, a measurement on waking up should be enough as some
patient go back to sleep after the dawn prayers. To guard against hypoglycemia, testing
in the last 2 h of the fasting period is recommended. Additional midday is useful
if morning readings were 100–120 mg or when any symptoms of hypoglycemia are experienced
or suspected. Several studies used different combinations of all of these which filtered
through various recommendations.[[9]],[[10]],[[11]],[[12]]
Continuous glucose monitoring systems
Kaplan and Afandi [[18]] assessed the impact of fasting on interstitial glucose (IG) in adolescents with
T1DM using CGM and concluded that adolescents with T1DM have a similar wide fluctuation
in IG during fasting in Ramadan as they do outside Ramadan. CGM (minimum 2.5 days)
was done on adolescents with T1DM during Ramadan fasting and in the months around
Ramadan to compare the differences in mean IG, and in the duration of hypoglycemia,
hyperglycemia, and severe hyperglycemia. Fourteen adolescents aged 15 ± 4 years with
diabetes for 6 ± 4 years, and mean HbA1c 8.6 ± 1.1% were studied. No difference in
the mean IG or the duration of hypoglycemia, hyperglycemia, and severe hyperglycemia
between Ramadan and nonRamadan period.
Using the flash glucose monitoring (FGM), the first comprehensive demonstration of
glucose changes during Ramadan fasting using FGM was reported in a small cohort included
individuals with different glucose intolerance states.[[20]] Also, Al-Agha et al.[[46]] reported on 51 participants from a pediatric diabetes clinic during Ramadan. They
were able to fast for 67.0% of the total days eligible for fasting, whereas they did
not fast on 33% of the days due to either hypoglycemia (15.4%) or nondiabetes-related
reasons (17.6%). None had severe hypoglycemia or DKA. Estimated HbA1c did not change.
Furthermore, Afandi et al.[[31]] elucidated the frequency, timing, and severity of hypoglycemia in 25 adolescents
with T1DM) while fasting the month of Ramadan who fasted Ramadan were monitored using
the same FGM system. Percentage and the total duration of hypoglycemia were extracted
from the FGM downloads, and the differences were compared between different times
of the day and night according to the eating pattern 18 in Ramadan. The mean age was
16 ± 3 years, and mean glycated hemoglobin was 8.6% ±1.2%, mean glucose level was
200 ± 84 mg/dl (11.1 ± 4.7 mmol/L), and the overall time spent in hypoglycemia was
5.7% ± 3.0%. The average daily time spent in hypoglycemia was 1.39 h [[19]],[[20]] per patient. The incidence of hypoglycemia was 0% from 19:00 to 23:00 p.m. and
69% from 11:00 to 19:00. Analysis of hypoglycemia revealed [[20]],[[21]] that 65% was between 61 and 70 mg/dl and 8% lower than 50 mg/dl. As the use of
FGM increases, more confidence and perhaps safety may be felt by patients, and more
insights into glucose homeostasis at different times of the day during fasting may
be gained.
Telemonitoring
Lee et al.[[47]] evaluated the benefits of a telemonitoring-supplemented focused diabetic education
compared with education alone in participants with T2DM who were fasting during Ramadan.
They identified 37 participants and randomly allocated them to either a telemonitoring
group or Ramadan-focused preeducation only. The authors observed no significant differences
in glycemic control at the end of the study. However, participants viewed telemedicine
as a more convenient alternative; although, technological barriers remain a concern.
Conclusions
Current limitations
Management of adolescents and children with diabetes during Ramadan fasting remains
a major bioethical and clinical challenge. Risks may be increased if no proper preRamadan
assessment, management, and targeted diabetes education is provided.[[36]]
The literature on Ramadan, in general, has for long included less evidence than consensus
and too many opinions and less actual evidence.[[48]],[[49]] This is possibly more obvious in pediatric than adult practices for various ethical
and biological reasons. The volume of current literature on the impact and management
of Ramadan fasting in children and adolescents with diabetes is increasing but not
large enough to address such an important issue relative to the number of people involved.[[6]],[[7]] Some of the conclusions are based on experience with adults and extrapolation to
children and adolescents. Available data suggest that Ramadan fasting at this age
group may be possible and appears to be safe provided that family and healthcare professionals
provide proper education and supervision. However, there is no place for complacency.
A sound medical advice should be based on assessment of the person's maturation, status
of glycemic control, and individual's ability to undertake self management.
There are several limitations to the Ramadan fasting studies in adolescents and children.
The small numbers in many of the studies published so far is a major factor influencing
the interpretation of results. It remains a challenge to recruit a “good” number at
this age group for ethical, social and pragmatic reasons. This challenge may be overcome
by carefully conducted multi-center trials using some of the individuals who choose
not to fast as the control group. Such trials should enable assessment of the risks
of hypoglycemia and hyperglycemia while using modern technology and newer insulin
preparations. Such multicenter studies, if conducted using unified protocols and predetermined
outcome measures, should enable pooling of data, take account of all potential confounders
and address several questions simultaneously. Furthermore, more comprehensive outcome
measures, rather than focusing on hypo and hyperglycemia, need to be included in the
evaluation of overall control. Assessments of diabetes-related quality of life targeting
detection of fear of hypoglycemia on the one hand compared to the potential for low
self-esteem when facing peer-pressure in those who choose not to fast. It is strongly
arguable that a single measurement during the fasting month may not be enough to reflect
the whole month. Factors such as lack of knowledge early in Ramadan contrasted with
the balance between confidence, experience or complacency in the last few weeks may
all be operative. The amount of physical exercise, schooling demands, and sick day
rules are different between countries where Ramadan-working hours are applied versus
other countries where they are not. The impact of knowledge, attitude, and practices
during Ramadan of the treating physicians, diabetes educators, patients and other
family members, and interplay thereof must be significant.[[27]]
Future directions
Recent developments such as the use of insulin pumps, insulin analogs, and recognition
of the importance of structured diabetes education and assessment should help select
the patients best suited for the rigors of fasting.[[36]] These may alter the traditional approach of doctors toward Ramadan fasting in both
adults and adolescents with T1DM. Sophisticated therapeutic options like smart insulins
may potentially provide safer and more convenient opportunities for the management
of T1DM during Ramadan. Also, other therapies adjuvant to insulin therapy may change
the scene.
These challenges cannot be addressed under the current fragmented Ramadan research
arrangements mostly driven by personal interest.[[48]],[[49]] Furthermore, the required volume and high quality of data cannot be readily collected
in busy clinics by otherwise fully committed practicing clinicians. Specifically,
research is needed for this high-risk group of children and adolescents as well as
other groups such as pregnant women, older adults, and patients with acute, advanced
and chronic medical conditions. Funding must be made available for dedicated research
fellows working under the guidance of experts to address impartial questions independent
of third party agenda. Ramadan research should be identified by academia of Muslim-majority
countries as a priority and a prime example of ethnically-sensitive care. Ramadan
research should feature in institutional strategic plans rather than left as a marginal
subject driven by personal interests.
However, for translation of the findings of research into clinical practice, focused
education is needed for patients, physicians, family members, and community leaders.
With the management of diabetes during Ramadan fasting in children and adolescents
in mind, an online survey of physicians' perceptions and practices in the Arab Society
for Pediatric Endocrinology and Diabetes (ASPED) countries revealed gaps in knowledge,
perceptions, and practices.[[50]] This was not much different from the knowledge gaps found in physicians charged
with the care of adults with diabetes detected in a previous survey.[[51]]. Physicians and their supporting staff need to be ready for the job of dispelling
myths, explaining religious rules, advising on lifestyle modifications, and making
the necessary changes in medications.[[52]],[[53]] This should be provided over and the above the standard diabetes care including
support, monitoring, and timely intervention.
Authors' contributions
All authors contributed to the conception, drafting, and revising of the manuscript.
They all approved its final version.
Compliance with ethical principles
Not applicable. No human or animal studies by the authors were reported.
